MyFinsight
Home
Blog
About
Proceeds related to
common stock...
$89,646K
(35193.70%↑ Y/Y)
Proceeds from issuance of
common stock allocated...
$3,688K
Proceeds from employee
stock purchase plan...
$245K
(-83.22%↓ Y/Y)
Net cash provided by
financing activities
$93,582K
(5964.94%↑ Y/Y)
Net decrease in
cash, cash...
-$26,727K
(52.22%↑ Y/Y)
Canceled cashflow
$93,582K
Proceeds from maturities
of marketable...
$15,751K
(-37.88%↓ Y/Y)
Proceeds from disposal of
assets
$23K
(-96.38%↓ Y/Y)
Change in the estimated
fair value of...
$16,362K
(100.42%↑ Y/Y)
Change in the estimated
fair value of success...
$7,551K
(86.21%↑ Y/Y)
Stock-based compensation
expense
$5,342K
(-60.87%↓ Y/Y)
Depreciation
$2,234K
(-65.66%↓ Y/Y)
Accrued expenses and
other liabilities
$1,122K
(109.44%↑ Y/Y)
Operating lease
right-of-use assets and...
-$556K
(-786.42%↓ Y/Y)
Non-cash expense for
operating lease...
$490K
(-89.02%↓ Y/Y)
Prepaid expenses and
other assets
-$295K
(60.14%↑ Y/Y)
Net cash provided by
(used in) investing...
-$87,519K
(-460.41%↓ Y/Y)
Canceled cashflow
$15,774K
Net cash used in
operating activities
-$32,790K
(59.89%↑ Y/Y)
Canceled cashflow
$33,952K
Purchases of marketable
securities
$101,672K
(5944.71%↑ Y/Y)
Purchases of property and
equipment
$1,621K
(6654.17%↑ Y/Y)
Net loss
-$63,635K
(55.56%↑ Y/Y)
Other non-cash items,
net
$2,256K
(-61.06%↓ Y/Y)
Accounts payable
-$851K
(71.62%↑ Y/Y)
Back
Back
Cash Flow
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)
source: myfinsight.com